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Introduction
Intestinal fluid transport is driven by active ion transport with
absorption being driven by cations and fluid secretion being driven
predominantly by Cl secretion [1]. Normally, absorption predom-
inates in the colon, allowing conservation of the large volume of
fluid that enters the intestine each day. However, secretory
processes are also ongoing and are required for appropriate hydra-
tion of the mucosal surface. This finely tuned balance between
absorption and secretion can be drastically altered in disease
states, leading to the clinical manifestation of diarrhoea. Cl secre-
tion is promoted by hormones and neuroimmune mediators, which
act at cell surface G-protein-coupled receptors (GPCRs). Activation
of GqPCRs elevates intracellular Ca2, whereas GsPCRs are linked
to increases in cytosolic cAMP. In turn, elevations in intracellular
messengers activate the epithelial transport machinery to promote
Cl secretion. At the molecular level the concerted activity of baso-
lateral Na/K ATPase pumps, NKCC1 (Na/K/2Cl cotrans-
porter) and K channels serve to elevate Cl within epithelial cells
so that an electrochemical gradient exists for its efflux to occur
when channels in the apical membrane are opened [2].
Upon ingestion of a meal, bile acids are released from the gall-
bladder into the small intestine where they aid in digestion and
absorption of lipids. Most bile acids are reabsorbed as they pass
through the distal small intestine, but with each cycle of the
enterohepatic circulation, a small fraction (~2%) enters the colon
where they undergo bacterial metabolism to form secondary bile
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Abstract
In patients with bile acid malabsorption, high concentrations of bile acids enter the colon and stimulate Cl and fluid secretion, thereby
causing diarrhoea. However, deoxycholic acid (DCA), the predominant colonic bile acid, is normally present at lower concentrations
where its role in regulating transport is unclear. Thus, the current study set out to investigate the effects of physiologically relevant DCA
concentrations on colonic epithelial secretory function. Cl secretion was measured as changes in short-circuit current across voltage-
clamped T84 cell monolayers. At high concentrations (0.5–1 mM), DCA acutely stimulated Cl secretion but this effect was associated
with cell injury, as evidenced by decreased transepithelial resistance (TER) and increased lactate dehydrogenase (LDH) release. In contrast,
chronic (24 hrs) exposure to lower DCA concentrations (10–200 M) inhibited responses to Ca2 and cAMP-dependent secretagogues
without altering TER, LDH release, or secretagogue-induced increases in intracellular second messengers. Other bile acids – taurodeoxy-
cholic acid, chenodeoxycholic acid and cholic acid – had similar antisecretory effects. DCA (50 M) rapidly stimulated phosphorylation
of the epidermal growth factor receptor (EGFr) and both ERK and p38 MAPKs (mitogen-activated protein kinases). The EGFr inhibitor,
AG1478, and the protein synthesis inhibitor, cycloheximide, reversed the antisecretory effects of DCA, while the MAPK inhibitors,
PD98059 and SB203580, did not. In summary, our studies suggest that, in contrast to its acute prosecretory effects at pathophysiolog-
ical concentrations, lower, physiologically relevant, levels of DCA chronically down-regulate colonic epithelial secretory function. On the
basis of these data, we propose a novel role for bile acids as physiological regulators of colonic secretory capacity.
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acids, the most prominent of which in human beings is deoxy-
cholic acid (DCA). Bile acids exert a range of effects on colonic
epithelial cells [3–7], and their role in promoting fluid and elec-
trolyte secretion is well documented. Pathological conditions that
increase bile acid delivery to the colon, such as short bowel syn-
drome [8, 9], defects in bile acid transporters [10], inflammatory
bowel disease [11, 12], microscopic colitis [13] and irritable
bowel syndrome [14], are often accompanied by diarrhoea.
Furthermore, bile acid sequestrants are well-established therapeu-
tic tools for alleviating diarrhoea in such conditions [8, 12, 13, 15,
16]. Mechanisms underlying promotion of intestinal fluid accumu-
lation by bile acids have been studied in animals and cultured
epithelia, where they have been shown to induce Cl secretion
[17–23]. However, although there are considerable interspecies
variations in concentrations of bile acids required to promote
secretion, in human beings it is clear that pathophysiological lev-
els must be attained before secretory responses occur [24].
Although links between pathophysiological concentrations of
colonic bile acids and increased fluid secretion are well estab-
lished, there is little known of their role in regulating transport
under physiological circumstances where colonic epithelia are
continuously exposed to relatively low bile acid levels. Thus, in the
present study we investigated the effects of low DCA concentra-
tions on colonic epithelial secretory function.
Materials and methods
DCA, cholic acid, carbachol (CCh) and forskolin (FSK) were purchased from
Sigma Chemical Co, UK. Tyrphostin AG1478, SB203580 and PD98059 were
obtained from Calbiochem (San Diego, CA). Anti-phospho-p38 and anti-phos-
pho-ERK antibodies were obtained from New England Biolabs (Beverley, MA).
Anti-EGF receptor (mouse monoclonal IgG1) was obtained from Upstate
Biotechnology Inc. (Lake Placid, NY). Anti-phosphotyrosine (PY20; mono-
clonal IgG2bk) was obtained from Transduction Labs (Lexington, KY). All
other reagents were of analytical grade and were obtained commercially.
Cell culture
T84 colonic epithelial cells were cultured in DMEM/Ham’s F12 media (1:1)
supplemented with 5% newborn calf serum (HyClone, Logan, UT) in an
atmosphere of 5% CO2 at 37C. For Ussing chamber/voltage clamp studies,
approximately 5  105 cells were seeded onto 12 mm Millicell-HA Transwells
(Millipore, Bedford, MA). For Western blotting experiments, approximately
106 cells were seeded onto 30 mm Millicel-HA Transwells. Cells were cultured
on filters for 10–15 days prior to use. Under these conditions T84 cells
develop the polarized, electrically resistant phenotype of native epithelial cells.
Electrophysiological measurements
T84 cell monolayers were washed in serum-free medium and treated with bile
acids as described in the figure legends. Cells were then mounted in Ussing
chambers (aperture 0.6 cm2), voltage-clamped to zero potential difference,
and monitored for changes in short-circuit current (Isc) using a VCC MC8
Voltage Clamp (Physiological Instruments, San Diego, CA). Under such con-
ditions secretagogue-induced Isc across T84 monolayers is wholly reflective
of changes in electrogenic Cl secretion [25]. Isc measurements were car-
ried out in Ringer’s solution containing (in mM) 140 Na, 5.2 K, 1.2 Ca2,
0.8 Mg2, 119.8 Cl, 25 HCO3, 2.4 H2PO42 and 10 glucose. Results were
normalized and expressed as Isc (A/cm2). Measurements of transepithe-
lial resistance (TER) were made using an EvOhm apparatus (World Precision
Instruments, Sarasota, FL) and results were expressed as 	cm2. For exam-
ining DCA effects on rat colonic ion transport male Sprague-Dawley rats
(200–250 g) were used. Animals were kept on a 12-hr light/dark cycle and
were given food and water ad libitum. Following anaesthesia (2% isofluorane
gas  2L O2/min) rats were killed by cervical dislocation and the distal colon
was removed, stripped of its smooth muscle layers, mounted in Ussing
chambers and Isc measurements  performed. Approval for these studies was
obtained from the Beaumont Hospital Ethics Committee.
Western blotting
After treatment T84 monolayers were lysed in ice-cold lysis buffer (1%
Triton-X-100, 1 mM NaVO4, 1 g/ml leupeptin, 1 g/ml pepstatin, 1 g/ml
antipain, 1 mM NaF, 1 mM EDTA and 100 g/ml PMSF in PBS). Lysates
were collected, centrifuged at 15,300 g for 10 min and the pellet discarded.
Supernatants were normalized for protein content, mixed with 2X gel 
loading buffer (50 mM Tris, pH 6.8, 2% SDS, 100 mM dithiothreitol, 0.2%
bromophenol blue, 20% glycerol), boiled for 3 min, separated by SDS-
PAGE and transferred to polyvinylidene fluoride (PVDF) membranes.
Membranes were preblocked in 1% blocking buffer for 30 min, followed by
incubation with primary antibody in 1% blocking buffer for 60 min. After
washing (x5) in Tris buffered saline with 1% Tween (TBST), membranes
were incubated with horseradish peroxidase (HRP)-conjugated secondary
antibodies in 1% blocking buffer for 30 min. After further washing in TBST,
immunoreactive proteins were detected by enhanced chemiluminescence.
Protein phosphorylation was quantified using Scion image software.
Western blots for phosphorylated proteins were routinely stripped and 
re-probed for total protein to ensure equal loading.
Intracellular Ca2 imaging
T84 cells grown on coverslips were loaded with 5 M Fura-2/AM (dissolved
in 0.01% Pluronic F-127 plus 0.1% DMSO) in physiological salt solution
(PSS; 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 10 mM D-glucose and 10 mM
HEPES-trimethylamine, pH 7.4) at room temperature for 30 min. Coverslips
were washed and mounted in a perfusion chamber on a Nikon microscope
stage. Cells were perfused with normal PSS for 5 min before adding CCh to
the perfusing solution. The ratio of Fura-2 fluorescence with excitation at
340 or 380 nm (F340/380) was measured every 3 sec, and images were cap-
tured with an intensified CCD camera (ICCD200) and a MetaFluor Imaging
System (Universal Imaging, Corporation, Downingtown, PA).
cAMP assay
Monolayers of T84 cells grown on 30 mm Millicell-HA Transwells were treated
with DCA for 24 hours. Cells were then exposed to FSK (10 M; 5 min) and
lysed with 0.1 M HCl. Lysates were centrifuged (15,300 g; 10 min) and cAMP
levels in the supernatants were quantified with a commercially available kit
(Sigma-Aldrich, UK). Results were expressed as pmol cAMP/mg protein.
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Statistical analysis
All data are expressed as mean 
 SEM for a series of n experiments. Where
applicable EC50 values were calculated by extrapolation of data from concen-
tration-response curves generated in separate experiments. Paired Student’s
t-tests were used to compare paired data. One-way ANOVA with the Student
Newman-Keuls post-test was used when three or more groups of data were
compared. P-values 0.05 were considered statistically significant.
Results
High concentrations of DCA acutely stimulate
colonic epithelial Cl secretion
We first analysed acute effects of DCA on Cl secretion across
voltage-clamped T84 cells. Bilateral addition of 1 mM DCA stimu-
lated a transient increase in Isc that rapidly returned towards base-
line over the course of 20 min (Fig. 1). The threshold concentra-
tion for this prosecretory effect of DCA was greater than 200 M
with an EC50 of 488.8 
 45.6 M (Fig. 1B). At concentrations
greater than 500 M, DCA reduced TER (EC50 982.5 
 194.2 M;
Fig. 1C), whereas at concentrations greater than 1 mM, DCA induced
cell lysis and lactate dehydrogenase (LDH) release (EC50  1.99 

9.5 mM; Fig. 1D). Figure 1E shows that within 1 hr after addition,
DCA (500 M) almost abolished TER across T84 monolayers.
However, if the bile acids was washed from the cells after 40 min,
there was a gradual restoration of TER. Twenty-four hours after
DCA exposure, the TER across monolayers from which DCA was
removed had returned to 54.9 
 7.3% of that in control cells
although continued exposure to the bile acid obliterated TER 
(Figs. 1E and 2E). Thus, upon removal of DCA the barrier function
of colonic epithelial cells can, at least partially, be restored.
Low concentrations of DCA chronically inhibit
colonic epithelial Cl secretion
Because human colonic epithelial cells in vivo are normally
exposed to DCA at concentrations that do not induce secretion
[26, 27], we examined the effects of prolonged exposure to low
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Fig. 1 Acute exposure to high concentrations of DCA stimulates Cl secretion across T84 cells. (A) Voltage-clamped monolayers of T84 cells were bilat-
erally exposed to DCA (1 mM) and Isc responses were recorded (n  5). (B) Voltage-clamped T84 cells were exposed to increasing concentrations of
bilateral DCA and maximal Isc responses were measured (n  5). (C) Monolayers of T84 cells were exposed to increasing concentrations of DCA for 
20 min after which TER was measured (n  3). (D) Aliquots of supernatants from cells exposed to DCA at varying concentrations for 20 min were
analysed for LDH release. Data are expressed as sample absorbance at 490 nm (n  3). (E) TER was measured across T84 cell monolayers exposed to
500 M DCA (bilateral). In one set of monolayers DCA was removed after 40 min (n  4). *P  0.05; ** P  0.01; *** P  0.001.
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concentrations of the bile acid on secretagogue-induced
responses. In cells exposed to DCA (50 M) for 24 hrs subse-
quent responses to a prototypical GqPCR agonist, CCh (100 M),
were attenuated to 49.5 
 3.6% of those in control cells (Fig. 2A;
n  26; P  0.001). The EC50 for this antisecretory effect was
44.3 
 3.8 M (n 5) (Fig. 2B) and the effects of DCA were max-
imal between 3 and 6 hrs (Fig. 2C). Chronic treatment with DCA
(50 M; 24 hrs) also reduced responses to thapsigargin (2 M),
which increases intracellular Ca2 in a receptor-independent fash-
ion, and to the cAMP-dependent secretagogue, FSK (10 M), to
50.6 
 5.3 (n 3; P 0.05) and 82.1 
 3.7% (n 7; P 0.05)
of those in control cells, respectively. Interestingly, cAMP-depend-
ent secretory responses were less sensitive to pretreatment with
DCA than were Ca2-dependent responses (Fig. 2C). Prolonged
exposure of T84 cells to DCA did not alter TER or LDH release until
concentrations more than 200 M were achieved (Fig. 2D and E).
Together, these data indicate that chronic exposure to low levels of
DCA decreases epithelial secretory capacity without causing
apparent cell damage.
We next analysed DCA effects on Cl secretion across sec-
tions of rat colon. In these experiments DCA was added apically
in order to more closely mimic in vivo situations where bile acids
are found in the lumen. As expected, high concentrations of DCA
(1 mM) stimulated a rapid and transient Isc response (Fig. 3A).
The effects of DCA were concentration-dependent with levels
more than 200 M being required for a prosecretory effect to
occur (Fig. 3B). However, when tissues were exposed to rela-
tively low concentrations of DCA (200 M) on the apical side for
prolonged periods (3 hrs), subsequent secretory responses to
CCh (100 M) or FSK (10 M) were significantly attenuated
(Fig. 3C). This effect of DCA was not associated with alterations
in tissue viability or integrity as indicated by transmucosal con-
ductance measurements. The conductance across control tis-
sues was 26.5 
 1.8 mS/cm2 compared to 29.7 
 3.7 mS/cm2
in DCA-pretreated tissues (n  5). Thus, similar to its effects in
cultured human colonic epithelia, prolonged exposure to rela-
tively low concentrations of DCA exerts antisecretory effects in
rat colonic mucosa.
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Fig. 2 Chronic exposure to low concentrations of DCA inhibits Cl secretion across T84 cells. (A) Monolayers of T84 cells were exposed to bilateral DCA
(50 M) for 24 hrs and subsequent Isc responses to CCh (100 M) were measured. (B) T84 cell monolayers were exposed to increasing concentrations
of DCA for 24 hrs after which Isc responses to CCh (100 M) were measured (n  5). (C) Cells were exposed to DCA (50 M) for varying periods after
which Isc responses to CCh (100 M; n  4) or FSK (10 M; n  4) were measured. (D) Monolayers of T84 cells were exposed to increasing concen-
trations of DCA for 24 hrs after which TER was measured (n  5). (E) Aliquots of supernatants from cells exposed to DCA at varying concentrations
for 24 hrs were analysed for LDH. Data are expressed as sample absorbance at 490 nM (n  3). * P  0.05; ** P  0.01; *** P  0.001.
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Structure–activity relationships for antisecretory
effects of bile acids
The secretory and antisecretory effects of other naturally occurring
bile acids were also examined. Taurodeoxycholic acid (TDCA, the
taurine conjugate of DCA) and cholic acid (CA, the trihydroxy, pri-
mary bile acid from which DCA is formed) were selected for study.
Similar to DCA, and as previously reported [19], TDCA stimulated
Cl secretion across T84 cells at relatively high concentrations with
an EC50 of 427.5 
 80.2 M (n  5) (Fig. 4A). In contrast, CA did
not alter basal Isc. However, similar to DCA, we found that pro-
longed exposure to relatively low concentrations of both TDCA and
CA inhibited secretory responses to CCh (Fig. 4B). In further analy-
ses we examined the ability of naturally occurring isomers of DCA
to alter agonist-stimulated Isc responses and found that both
isodeoxycholic acid (iso-DCA) and lagodeoxycholic (lago-DCA)
acid were approximately equipotent to DCA in exerting antisecre-
tory effects (Table 1). Similarly, the dihydroxy primary bile acid,
chenodeoxycholic acid (CDCA), was also found to be equipotent
with DCA in inhibiting agonist-stimulated secretory responses.
Finally, we examined the sidedness by which conjugated and
unconjugated bile acids exert their antisecretory effects. Although
DCA was equally effective when applied either apically or basolat-
erally, TDCA was active only on the basolateral side (Fig. 4C).
The antisecretory effects of DCA are not mediated
by muscarinic receptor activation or by alterations
in the second messenger levels
Previous studies suggest bile acids can exert biological effects
through activation of muscarinic M3 receptors [28]. However, we
found that although it abolished responses to CCh (data not shown),
the muscarinic receptor antagonist, atropine (1 M), did not pre-
vent the antisecretory effect of DCA (Fig. 5A). We also examined the
possibility that DCA exerts antisecretory effects by altering secreta-
gogue-induced mobilization of the second messengers. However, 
in cells pretreated with DCA (50 M, 24 hrs), neither CCh-stimulated
mobilization of intracellular Ca2 nor FSK-induced accumulation of
cAMP was altered (Fig. 5B and C). These data suggest that DCA
exerts its antisecretory effects downstream from agonist-induced
mobilization of prosecretory second messengers.
EGFr transactivation and de novo protein synthesis
mediate the antisecretory effects of DCA
Our previous work has identified the epidermal growth factor
receptor (EGFr) and mitogen-activated protein kinases (MAPKs)
as important regulators of epithelial secretory responses [29, 30].
Furthermore, others have shown that bile acids induce EGFr and
extracellular signal-regulated kinase (ERK) activation in colonic
epithelia [5, 31, 32]. Thus, we examined a potential role for the
EGFr and MAPKs in mediating antisecretory effects of DCA. As
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Fig. 3 Prolonged exposure to physiological concentrations of DCA
inhibits Cl secretion across rat colon. (A) Voltage-clamped segments of
stripped rat colonic mucosa were apically exposed to DCA (1 mM) and
Isc responses were recorded (n 5). (B) Voltage-clamped sections of rat
colon were exposed to increasing concentrations of apical DCA and max-
imal Isc responses were measured (n  4–7 for each concentration
tested). (C) Voltage-clamped rat colonic mucosa was exposed to 200 M
apical DCA and after 3 hrs incubation subsequent Isc responses to CCh
(100 M; n  4) and FSK (10 M; n  5) were measured. *** P 
0.005 when compared to control cells.
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shown in Fig. 6A and B, DCA (50 M) rapidly stimulated EGFr
phosphorylation and pretreatment with the EGFr inhibitor, tyr-
phostin AG1478 (100 nM), reversed the antisecretory effects of
the bile acid (Fig. 6C). DCA also activated both ERK and p38
MAPKs (Fig. 7A). However, although PD98059 (20 M) and
SB203580 (10 M) effectively prevented DCA-induced ERK 
and p38 phosphorylation, respectively, neither inhibitor prevented
the antisecretory actions of DCA (Fig. 7B and C). However, inhibi-
tion of protein translation with cycloheximide (CHX; 100 ng/ml),
was found to attenuate the antisecretory actions of DCA (Fig. 7D).
Discussion
In the present study we demonstrate for the first time that bile
acids exert directly opposing actions on colonic epithelial cells
when they are present at high or low concentrations. These data
are likely to be important when considering the role that bile acids
play in regulating colonic transport both in normal conditions and
in disease states. Increased bile acid delivery to the colon is a fea-
ture of many pathological conditions and it is likely that diarrhoea
associated with such conditions is primarily because of the pros-
ecretory actions of dihydroxy bile acids [9, 18]. We observed
secretory responses to DCA in cultured human colonic epithelial
cells and rat colon only to relatively high (i.e. 200 M) concen-
trations and as its levels increased beyond this threshold, DCA
became cytotoxic. These data are reminiscent of previous studies
in animal models and human beings [24, 33, 34], and on the
basis of these observations we propose that increased Cl and
fluid secretion occurring in response to high levels of bile acids
likely serves as a protective mechanism that dilutes the luminal
contents before epithelial damage can occur. This hypothesis is
supported by our findings that epithelial barrier function, as
measured by changes in TER, was partially restored upon
removal of DCA.
Normally, however DCA is present in human colon at levels lower
than those that promote secretion and we found that at such concen-
trations (i.e. 200 M), prolonged exposure to DCA reduced
responses to both Ca2- and cAMP-dependent secretagogues. The
EC50 for this antisecretory effect of DCA was approximately 75 M,
which is expected to be well within the physiological range in human
proximal colon in vivo [26, 27]. Our findings in cultured epithelial
cells were supported by those obtained in rat colon, in that apical
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Fig. 4 Structure–activity relationships for bile acids in regulating epithelial
secretory function. (A) Monolayers of T84 cells were exposed bilaterally to
increasing concentrations of DCA (n  5), TDCA (n  5), or cholic acid
(n  3) and maximal Isc responses were measured. (B) T84 cell monolay-
ers were exposed to increasing concentrations of bilateral DCA (n  5),
TDCA (n  4), and cholic acid (n  5) for 24 hrs after which secretory
responses to CCh (100 M) were measured. (C) Monolayers of 
T84 cells were exposed to DCA (50 M; n  4) or TDCA (200 M; n  4)
on the apical, basolateral, or both sides for 24 hrs after which cells were
voltage-clamped and subsequent secretory responses to CCh (100 M)
were measured. ** P  0.01; *** P  0.001.
Table 1 Antisecretory effects of dihydroxy bile acids in T84 cells
Bile acid (50 M)
Hydroxyl group
positions
% Control Isc response 
to CCh (100 M)
Deoxycholic acid 3-12-OH 52.5 
 6.0 (n  9; P  0.001)
Isodeoxycholic acid 3-12-OH 58.5 
 7.8 (n  3; P  0.05)
Lagodeoxycholic acid 3-12-OH 57.5 
 7.3 (n  6; P  0.001)
Chenodeoxycholic acid 3-7-OH 51.4 
 7.4 (n  6; P  0.001)
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addition of DCA at a concentration that did not acutely promote
secretion, chronically inhibited subsequent agonist-induced
responses. Thus, our data suggest that, in direct contrast to its pros-
ecretory actions at high concentrations, DCA at more physiological
levels exerts long-term antisecretory effects on colonic epithelia.
Other bile acids, including CDCA and TDCA, were found to share
the antisecretory properties of DCA. However, in contrast to DCA, a
relatively lipophilic molecule that is effective both apically and baso-
laterally, TDCA was effective only from the basolateral side. We have
previously shown a similar polarity to TDCA actions in promoting
secretion at high concentrations [18], and our findings are consistent
with the view that basolateral transporters are necessary for uptake
of hydrophilic, conjugated bile acids into colonic epithelia [23, 25,
35]. We also examined the effects of the naturally occurring isomers
of DCA, isodeoxycolic acid and lagodeoycholic acid. We have previ-
ously shown that, similar to DCA, lago-DCA acutely stimulates Cl
secretion across colonic epithelial cells at high concentrations,
whereas iso-DCA was without effect [18]. However, in the present
study we found that prolonged exposure to low concentrations of
either iso- or lago-DCA exerted antisecretory actions with a similar
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Fig. 5 The antisecretory effect of
DCA is not mediated by muscarinic
receptors or by alterations in ago-
nist-induced generation of the sec-
ond messengers. (A) Cells were
pretreated with atropine (1 M) for
30 min prior to DCA (100 M).
After a further 24 hrs incubation,
cells were washed and Isc
responses to FSK (10 M) were
measured (n  5). (B) T84 cells
grown on glass coverslips were
pretreated for 24 hrs with DCA 
(50 M) after which CCh-induced
mobilization of intracellular Ca2
was measured by Fura-2 fluores-
cence. Data are expressed as mean
fluorescence ratio at 340 and 380 nM
(n  3 coverslips for each condi-
tion). The inset shows the net
change in mean fluorescence ratio
(F340/380) for these experiments.
(C) Monolayers of T84 cells were
treated with DCA (50 M) for 24 hrs
and then stimulated with FSK 
(10 M) for 5 min, lysed, and intra-
cellular cAMP was measured (n 4).
** P  0.01.
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potency to DCA. In contrast to DCA and its isomers, we found that
the primary bile acid, cholic acid, was devoid of prosecretory actions.
This is in agreement with previous studies demonstrating that only
bile acids with two -hydroxyl groups exert prosecretory activity 
[34, 36]. However, similar to the dihydroxy bile acids, CA exerted
antisecretory actions upon prolonged exposure to epithelial cells.
Although it is unlikely that such high concentration of CA would
occur in the colonic lumen under normal conditions, these data
demonstrate a marked difference in structure–activity relationships
for pro- and antisecretory actions of bile acids and suggest that these
actions are likely to be mediated by distinct mechanisms.
Similar to our previous studies showing that prosecretory
actions of DCA do not involve muscarinic receptor activation [18],
we found that the antisecretory effect of DCA was also independ-
ent of muscarinic receptor activation. Thus, mechanisms by which
bile acids regulate epithelial transport appear to be distinct from
the M3 receptor-dependent pathway that has been reported to
mediate their effects on cell growth [5]. Furthermore, because low
concentrations of DCA did not alter secretagogue-induced mobi-
lization of prosecretory second messengers, our data suggest that
DCA exerts its antisecretory actions at a point distal to generation
of prosecretory second messengers.
The EGFr is emerging as an important regulator of epithelial trans-
port [29, 37, 38] and because bile acids can induce EGFr activation in
some systems [5, 31, 32, 39], we hypothesized that it might mediate
the antisecretory actions of DCA in colonic epithelia. This appears to
be the case because DCA rapidly induced EGFr phosphorylation, and
a specific EGFr inhibitor, tyrphostin AG1478, at least partially reversed
the antisecretory effects of DCA. However, although DCA also stimu-
lated activation of both ERK and p38, inhibition of either of these
MAPKs did not alter the actions of the bile acid. In light of the previ-
ous studies showing that EGFr/MAPK signalling mediates cell growth
in response to bile acids [5], these data are intriguing in that they sug-
gest that the EGFr transduces independent signals to differentially
regulate cell growth and ion transport in response to bile acids.
Although DCA-induced antisecretory signalling mechanisms down-
stream of the EGFr remain to be identified, it is likely that de novo pro-
tein synthesis is involved because these actions are slow in onset and
are sensitive to the inhibitor of protein translation, cycloheximide.
Furthermore, because DCA induces a generalized and sustained
down-regulation in epithelial secretory capacity, it is likely that it ulti-
mately acts by altering the expression and/or activity of a transport
protein involved in the Cl secretory pathway. Experiments are cur-
rently underway in our laboratory to investigate this hypothesis.
The physiological/pathophysiological significance of opposing
actions of bile acids at low and high concentrations is as yet unclear.
However, based on data from our own and previous studies we put
forward the following hypothetical model. Normally, colonic DCA
levels are relatively low and it exerts antisecretory actions, which, 
in vivo, would serve to promote normal colonic absorptive function.
However, as absorption proceeds and the luminal contents become
dehydrated, bile acid concentrations would increase. When a certain
threshold concentration is reached, DCA becomes acutely prosecre-
tory, which in vivo would serve to rehydrate the luminal contents,
thereby preventing bile acid concentrations from achieving suffi-
cient levels to exert cytotoxic actions. In turn, as it becomes diluted
DCA would again become antisecretory. In this way, we propose a
novel role for bile acids as colonic ‘osmosignals’ that dynamically
regulate the fluidity of the luminal contents. However, it must 
be acknowledged that the situation in vivo is more complex than in
the models employed here and factors such as mucosal blood flow,
the unstirred mucous layer, luminal bacteria and fluctuations in pH
are all likely to alter the bioavailability of bile acids to epithelial cells.
In summary, we have identified novel antisecretory actions of
DCA, and other bile acids, on colonic epithelial cells when they are
present at relatively low concentrations. This effect appears to 
be mediated by an EGFr-dependent signalling pathway, requires
de novo protein synthesis and interferes with the secretory mech-
anism at a point distal to the second messenger generation. Our
© 2009 The Authors
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Fig. 6 EGFr activation mediates the antisecretory effect of DCA in colonic
epithelial cells. (A) Cells were treated with DCA (50 M; bilateral) for the
times indicated after which EGFr phosphorylation was measured by
immunoprecipitation and Western blotting. (B) Densitometric analysis of
several similar experiments (n  3). (C) Cells were pretreated with tyr-
phostin AG1478 (100 nM) for 30 min prior to DCA (50 M). After a fur-
ther 24 hrs incubation, cells were mounted in Ussing chambers and Isc
responses to CCh (100 M) were measured. Responses to CCh in DCA-
treated cells were expressed as percentage of vehicle or AG1478-treated
controls, as appropriate. Single asterisk ‘*’ denotes significant differences
from cells stimulated with CCh alone (n  5; * P  0.05; ** P  0.01).
Symbol ‘#’ denotes significant difference from cells pretreated with DCA.
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data suggest a novel role for bile acids as colonic osmosignals,
and future studies will aim to more fully elucidate the molecular
mechanisms involved in transducing their effects both in physio-
logical and pathophysiological conditions.
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Fig. 7 Inhibition of protein synthesis but not ERK or p38 MAPK blocks the antisecretory effect of DCA in colonic epithelial cells. (A) Cells were treated bilat-
erally with DCA (50 M) for the times indicated after which cell lysates were analysed by Western blotting with anti-phospho-ERK or anti-phospho-p38
antibodies. Each blot is representative of three similar experiments. (B–D) Cells were pretreated with either (B) PD98059 (20 M), (C) SB203580 (10 M)
or (D) cycloheximide (100 ng/ml) for 30 min prior to DCA (50 M). After a further 24 hrs incubation, cells were mounted in Ussing chambers and Isc
responses to CCh (100 M) were measured. The insets to Fig. 7B and D show that PD98059 and SB203580 inhibited DCA-stimulated ERK and p38 phos-
phorylation, respectively (these blots are representative of three similar experiments). Responses to CCh in DCA-treated cells were expressed as percent-
age of vehicle or inhibitor-treated controls, as appropriate (n  5; * P  0.05; ** P  0.01; *** P  0.001 compared to cells stimulated with CCh alone).
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